President Donald Trump and the Centers for Medicare & Medicaid Services (CMS) recently announced the 15 drugs whose prices ...

The Trump administration on Tuesday announced the next round of prescription drugs up for Medicare price negotiations.

The Centers for Medicare & Medicaid Services (CMS) announced that Botox is among 15 prescription drugs newly added to the ...

Medicare selects Botox and Trulicity among 15 high-cost drugs for price negotiations under new federal authority, with lower ...

List includes medications for diabetes, cancer, arthritis, and more ...

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Medicare picks Botox and Trulicity for latest round of negotiations The Centers for ...

Fifteen prescription medications, including Botox and the diabetes drug Trulicity, will be the focus of federal price ...

The Trump administration kicked off another round of Medicare drug price negotiations, while Kaiser Permanente agrees to pay ...

About 1.8 million people used one or more of the 15 drugs through Medicare Part D or Part B between November 2024 and October 2025, the CMS said. The batch of 15 meds accounted for about $27 billion ...

CMS has announced that the new cycle of drug price negotiations by Medicare will include big-name drugs for diabetes and HIV/AIDS, as well as Botox injections. 1,2 The 15 high-cost prescription drugs ...

The Trump administration released the next 15 drugs subject to Medicare price negotiation, including for the first time ...